IL1RN
The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jan 2016]
Full Name
Interleukin 1 Receptor Antagonist
Function
Inhibits the activity of interleukin-1 by binding to receptor IL1R1 and preventing its association with the coreceptor IL1RAP for signaling. Has no interleukin-1 like activity. Binds functional interleukin-1 receptor IL1R1 with greater affinity than decoy receptor IL1R2; however, the physiological relevance of the latter association is unsure.
Cellular Location
Isoform 1: Secreted
Isoform 2&3&4: Cytoplasm
Isoform 2&3&4: Cytoplasm
Involvement in disease
Microvascular complications of diabetes 4 (MVCD4):
Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis.
Interleukin 1 receptor antagonist deficiency (DIRA):
A rare autoinflammatory disease of skin and bone resulting in sterile multifocal osteomyelitis, periostitis, and pustulosis from birth. The term autoinflammatory disease describes a group of disorders characterized by attacks of seemingly unprovoked inflammation without significant levels of autoantibodies and autoreactive T-cells.
Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis.
Interleukin 1 receptor antagonist deficiency (DIRA):
A rare autoinflammatory disease of skin and bone resulting in sterile multifocal osteomyelitis, periostitis, and pustulosis from birth. The term autoinflammatory disease describes a group of disorders characterized by attacks of seemingly unprovoked inflammation without significant levels of autoantibodies and autoreactive T-cells.
View more
Anti-IL1RN antibodies
+ Filters
Loading...
CompareTarget: IL1RN
Specificity: Human
Target: IL1RN
Specificity: Human
Target: IL1RN
Specificity: Human
Target: IL1RN
Specificity: Human
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBHb151
Application*: IHC-F, Immuno assays, WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 20D8
Application*: WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: S14
Application*: WB, E
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBFYA-0094
Application*: C, IA, WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBYY-I2019
Application*: WB, IH
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBYY-I1981
Application*: WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBYY-I1978
Application*: WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-I1976
Application*: WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBYY-I1958
Application*: WB, IH
Target: IL1RN
Host: Rat
Antibody Isotype: IgG2
Specificity: Mouse
Clone: CBYY-I1089
Application*: WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: CBYY-I1078
Application*: E
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBYY-I1008
Application*: WB
Target: IL1RN
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBYY-I0966
Application*: P
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: AS17
Application*: F, IS, E
Target: IL1RN
Host: Rat
Antibody Isotype: IgG1
Specificity: Mouse
Clone: CBYY-I0696
Application*: WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 5F11H11
Application*: E, WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-I0279
Application*: E
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 2D11
Application*: E, WB, C, C, F, R
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: 1H5
Application*: E, IP, WB
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 10309
Application*: N, E
Target: IL1RN
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBYY-I0167
Application*: F, IF, IF
Target: IL1RN
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBYY-I0164
Application*: IF, F
More Infomation
Hot products 
-
Mouse Anti-BRCA2 Recombinant Antibody (CBYY-0790) (CBMAB-0793-YY)
-
Rat Anti-(1-5)-α-L-Arabinan Recombinant Antibody (V2-501861) (CBMAB-XB0003-YC)
-
Rabbit Anti-B2M Recombinant Antibody (CBYY-0059) (CBMAB-0059-YY)
-
Mouse Anti-AMACR Recombinant Antibody (CB34A) (CBMAB-CA034LY)
-
Mouse Anti-ADGRE2 Recombinant Antibody (V2-261270) (CBMAB-C0813-LY)
-
Mouse Anti-ASH1L Monoclonal Antibody (ASH5H03) (CBMAB-1372-YC)
-
Mouse Anti-8-oxoguanine Recombinant Antibody (V2-7697) (CBMAB-1869CQ)
-
Rabbit Anti-ABL1 (Phosphorylated Y245) Recombinant Antibody (V2-505716) (PTM-CBMAB-0465LY)
-
Mouse Anti-EMP3 Recombinant Antibody (CBFYE-0100) (CBMAB-E0207-FY)
-
Rat Anti-EPO Recombinant Antibody (16) (CBMAB-E1578-FY)
-
Mouse Anti-ATP1B1 Recombinant Antibody (E4) (CBMAB-0463-LY)
-
Mouse Anti-8-oxoguanine Recombinant Antibody (V2-7719) (CBMAB-1898CQ)
-
Mouse Anti-ENO1 Recombinant Antibody (CBYC-A950) (CBMAB-A4388-YC)
-
Mouse Anti-CGAS Recombinant Antibody (CBFYM-0995) (CBMAB-M1146-FY)
-
Mouse Anti-CD33 Recombinant Antibody (P67.6) (CBMAB-C10189-LY)
-
Mouse Anti-AKT1 Recombinant Antibody (V2-180546) (CBMAB-A2070-YC)
-
Mouse Anti-EIF4G1 Recombinant Antibody (2A9) (CBMAB-A2544-LY)
-
Mouse Anti-ARSA Recombinant Antibody (CBYC-A799) (CBMAB-A3679-YC)
-
Mouse Anti-C5b-9 Recombinant Antibody (aE11) (CBMAB-AO138LY)
-
Mouse Anti-CARD11 Recombinant Antibody (CBFYC-0811) (CBMAB-C0866-FY)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry